HCW Biologics prices USD 4 million private placement at USD 1.41 per unit

HCW Biologics, Inc.

HCWB

0.00

HCW Biologics priced a private placement of 2,846,975 units at USD 1.41 per unit, for gross proceeds of about USD 4 million.
Each unit includes one common share or a pre-funded warrant, plus one warrant to buy one common share at an exercise price of USD 1.28; the warrants are exercisable immediately, expire in 5.5 years.
Proceeds are earmarked for clinical and preclinical development programs, general corporate purposes, debt repayment, and settlements.
E.F. Hutton is the sole placement agent.
HCW Biologics agreed to file a resale registration statement on Form S-1 within 60 days of closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605210953PRIMZONEFULLFEED9724745) on May 21, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.